Multiple Sclerosis News Today | Symptoms, Diagnosis, Treatments
6 days ago · November 5, 2024 News by Marisa Wexler, MS. EC slaps Teva with €463M fine over misuse of Copaxone patents. The European Commission (EC) fined Teva Pharmaceuticals …
Treatment of progressive MS hits milestones in recent years: Study
August 14, 2024 News by Esteban Domínguez Cerezo, MS. Phase 1 trial to begin of CAR T-cell therapy azer-cel for progressive MS. July 12, 2024 News by Katherine Poinsatte, PhD.
MRI analysis of MS ReBUILD data shows remyelination with...
Jun 16, 2023 · October 8, 2024 News by Esteban Domínguez Cerezo, MS. Nerve stimulator for myelin repair to enter RRMS clinical trial. March 6, 2024 News by Marisa Wexler, MS.
About Us - Multiple Sclerosis News Today
About Multiple Sclerosis News Today. Multiple Sclerosis News Today is a digital platform intended to provide the multiple sclerosis (MS) community with the most recent news and information …
MS prognosis and life expectancy - Multiple Sclerosis News Today
Feb 13, 2024 · But when most patients received treatment, only about 10% converted to SPMS, and over a median of 32 years. In approximately 15% of MS patients, the disease will enter a …
The MS News Today Podcast - Multiple Sclerosis News Today
Jenn is the Brand and Marketing Manager for Bionews (Multiple Sclerosis News Today is a subsidiary of Bionews). Jenn is also the host of the Multiple Sclerosis Podcast as well as a …
1-year fenebrutinib inhibits nearly all MS signs in relapsing MS trial
Sep 6, 2024 · The Phase 2 FENopta trial (NCT05119569) evaluated fenebrutinib’s safety and efficacy in 109 adults, ages 18-55, with relapsing forms of MS, including relapsing-remitting …
Top 10 MS stories of 2023 - Multiple Sclerosis News Today
News; Top 10 MS stories of 2023 Top 10 MS stories of 2023. Of most interest to readers was news on potential treatments, triggers. by Marisa Wexler, MS | January 2, 2024.
ACTRIMS 2024: 2 treatments to aid remyelination in MS nearing...
Mar 6, 2024 · CVL-1001 inhibits EBP protein, while CVL-2001 blocks the activity of CYP51. by Marisa Wexler, MS March 6, 2024. Convelo Therapeutics is developing two experimental oral …
MS Vaccine to Prevent Immune System Attacks on Myelin Being …
Feb 9, 2022 · October 30, 2024 News by Marisa Wexler, MS. Brain blood vessels key to new MS treatments, researchers argue. June 14, 2024 News by Steve Bryson, PhD.